Navigation Links
Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
Date:1/12/2009

SAN FRANCISCO and YONGIN, South Korea, Jan. 12 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Ontario), and its South Korean partner Green Cross Corp., today announced treatment of the first five patients in a Phase 2 primary liver cancer clinical trial using its targeted and armed poxvirus JX-594. No significant toxicities were reported, and enrollment of patients onto the trial is continuing.

The Phase 2 trial involves treatment of patients with advanced, primary liver cancer refractory to standard therapies. Patients are randomized to receive treatment at one of two dose levels. The 30-patient, multi-national trial is being conducted at clinical sites in the United States, South Korea and Canada.

"We're very excited to have this trial open and enrolling with our lead product, JX-594, which has the potential to revolutionize the treatment of the more than 10,000 patients each year who develop liver cancer in the U.S. alone. The numbers of patients with liver cancer in the EU, Japan and Asia are even higher. These desperate patients represent a huge unmet medical need since few effective therapies are available for them," said David H. Kirn, M.D., President and Chief Executive Officer of Jennerex.

"We have already treated four patients with JX-594 in Korea and are anxious to see the efficacy of JX-594 in these late stage liver cancer patients," said B.G. Rhee, Ph.D., Executive Vice President of Green Cross.

The primary objective for this trial is to study the efficacy of treatment with JX-594 at two different dose levels in preventing tumor progression, as measured by modified RECIST criteria at eight weeks from initiation of treatment in patients with unresectable primary hepatocellular carcinoma. In addition, safety and tolerability, as well as tumor response and progression-free survival, of JX-594 administered at the two dose levels will be evaluated. Up to
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
2. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
3. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
4. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
5. New Study Shows LEVITRA Successfully Treats Erectile Dysfunction (ED) in Men with Dyslipidemia, Including High Cholesterol
6. New Data Shows Veramyst Effectively Treats Symptoms of Perennial Allergic Rhinitis
7. New Topical Therapy Safely Treats Serious Skin Infections Without Systemic Side Effects
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
10. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
11. Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 20, 2015 Research ... of the "Guide to Prepare Application Dossiers ... China (2014 Edition) " report to their ... is one of segment market of the most ... overseas medical device manufacturers and producers to penetrate ...
(Date:5/22/2015)... , May 22, 2015 ... clinical research unit with a worldwide reputation for ... its frequent publications in peer reviewed medical journals. ... stakeholders and regulators in discussions about rules for ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 ... has announced the addition of the "North ... & Graft), by Application (Surgical Wound, & Ulcer), ... Forecast to 2019" report to their offering. ... wound care market is estimated to grow at ...
Breaking Medicine Technology:China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2
... Sept. 21 The Association of Medical Media (AMM) ... highest-scoring medical journal advertisements Thursday, September 16, 2010.   ... annual study developed by AMM, researches physician attitudes toward ... 21 specialties from the 86 most widely-advertised products in ...
... More than one in three diabetes patients skip doses ... they have done so on average three times in the ... reality this number could be as high as six doses*, ... Insulin Therapy (GAPP™) survey, released today by Novo Nordisk. ...
Cached Medicine Technology:AMM Names 2010 Doctors' Choice Awards Winners 2AMM Names 2010 Doctors' Choice Awards Winners 3New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed 2New Global Survey Reveals Over One in Three Patients Fail to Take Insulin as Prescribed 3
(Date:5/24/2015)... (PRWEB) May 24, 2015 Scientists with ... paper on air quality compliance issues that may have ... workers. Surviving Mesothelioma has just posted an article on ... , The group found airborne asbestos levels well ... collected between 1984 and 2011. , “Asbestos compliance sampling ...
(Date:5/24/2015)... Scottsdale, Arizona (PRWEB) May 24, 2015 ... hired former Millennial Media strategy executive Jay Krihak ... as Medicx looks to ramp up its expertise ... services of the Pharmaceutical and Health sectors. , ... ad tech executive. Most recently, Krihak led sales ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 Dr. David Benvenuti, ... has just posted a new article to his ... As Dr Benvenuti explained in the fascinating blog, ... plugs in their earlobes. , Known as “gauging,” the technique ... hole, which Dr. Benvenuti said will eventually stretch the holes ...
(Date:5/23/2015)... A live auction will be held to sell ... and other medical facilities around the United States. Various ... surgery, anesthesia, exam and much more. , The live ... 28 starting at 9:00am CDT each day. The equipment is ... Melrose Park, IL 60160. Anyone can participate in the ...
(Date:5/22/2015)... 2015 Pioneer Millworks, the largest reclaimed ... of designing with reclaimed wood, introducing their latest reclaimed ... California. Their newest offerings, Vat 35, Reclaimed Teak ... color to America's largest design event. , “Designers, architects, ... show, anxious to see and feel the variety of ...
Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Medicx Media Solutions Expands Executive Team 2Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3
... shows that the prevalence of hay fever and eczema in ... risen sharply.// ,In the research that has been ... the University of Edinburgh have said that the rates of ... years of steady rise but at the same time allergic ...
... of developing lymphoma and leukemia. The autoimmune, inflammatory disease ... the risk of cancer. //Researchers speculate that antirheumatic drugs ... a type of biologic DMARD may play a role ... attaching to and impeding chemical messengers behind inflammation, have ...
... Researchers say that in Asian children must be given Vitamin ... order to avert the reappearance of deficiency symptoms. //Researchers examined ... and have published their findings in the latest issue of ... can cause rickets, poor tooth formation, convulsions, general ill health, ...
... who carried donor cards no longer have the last say ... new laws will come into force that will make the ... carry a donor card, their relatives can prevent doctors from ... reported to do so. ,The new laws have come into ...
... in traumatic head injuries among Canadians under age 19 ... released on Wednesday.// ,When the Canadian Institute for ... injuries from 1994 to 2004 it found that overall, ... with children and youth showing the largest drop. ...
... are genetically more suited to being vegetarians than meat-eaters is ... by more then 300 leading scientists from New Zealand and ... a cure for cancer is also under discussion at the ... of the conference says the finding that a human is ...
Cached Medicine News:Health News:Eczema And Hay Fever Decline In UK While Allergic Reactions On The Rise 2Health News:RA Drugs Not Implicated In Cancer 2Health News:Asian Children Need More Vitamin D Supplements 2Health News:Families of the Dead no Longer Have the Last Say 2Health News:Families of the Dead no Longer Have the Last Say 3
... amplifier in the world. ,XLTEK EEG ... for accurate data acquisition with 500 Hz ... the highest signal-to-noise ratios available and fast ... All of this is for one purpose ...
... The cold-light illumination can be used ... the Head-worn Loupe KF Titanium and the ... the almost coaxial illumination, even in unfavorable ... The flexible, lightweight liquid light guide ensures ...
The SL 115 Classic Slit Lamp offers you high optical performance and convenient operation. It is not only the ideal instrument for all routine examinations and contact lens fitting, but is also excel...
... from Bausch & Lomb provides fingertip control ... one handed delivery of the IOL directly ... bag is assured by planar delivery. Leading ... into the capsular bag without sweeping motion. ...
Medicine Products: